|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2002-8-28
|
|
pubmed:abstractText |
Aspirin is widely used as an anti-thrombotic drug; however, it has been suggested that enteric-coated formulations of aspirin may be less bioavailable and less effective as anti-thrombotic agents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1683-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12197849-Adolescent,
pubmed-meshheading:12197849-Adult,
pubmed-meshheading:12197849-Aspirin,
pubmed-meshheading:12197849-Blood Platelets,
pubmed-meshheading:12197849-Double-Blind Method,
pubmed-meshheading:12197849-Drug Administration Schedule,
pubmed-meshheading:12197849-Female,
pubmed-meshheading:12197849-Humans,
pubmed-meshheading:12197849-Male,
pubmed-meshheading:12197849-Middle Aged,
pubmed-meshheading:12197849-Platelet Aggregation,
pubmed-meshheading:12197849-Platelet Aggregation Inhibitors,
pubmed-meshheading:12197849-Tablets, Enteric-Coated,
pubmed-meshheading:12197849-Thromboxane B2
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
|
|
pubmed:affiliation |
Center for Clinical Pharmacology, University Hospital Gasthuisberg, Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
